Unicycive Therapeutics (UNCY) Return on Equity [ROE] (2021 - 2026)
Unicycive Therapeutics' Return on Equity [ROE] came in at -69.73% for Q2 2026, up 142.66 percentage points from -212.39% a year earlier and up 15.22 percentage points from the prior quarter.
Powered by 
Analysis
Unicycive Therapeutics (UNCY) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Unicycive Therapeutics' Return on Equity [ROE] was -151.89%, up 1555.84 percentage points from FY2024.
- Return on Equity [ROE] carries a four-year change of -12.82 percentage points (FY2021 to FY2025).
- Going back by year, Return on Equity [ROE] was -1707.73% in FY2024, -225.47% in FY2022 (-86.40 pp) and -139.07% in FY2021.
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q4 2021.
- Business Quant data shows UNCY's Return on Equity [ROE] at -84.95% (Q1 2026), -84.45% (Q4 2025) and -113.69% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Unicycive Therapeutics | 101.95 Mn | -98.02 Mn | - | -69.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -69.77% |
| Mar 31, 2026 | -85.00% |
| Dec 31, 2025 | -84.45% |
| Sep 30, 2025 | -113.69% |
| Jun 30, 2025 | -212.39% |
| Mar 31, 2025 | -316.01% |
| Dec 31, 2022 | -895.72% |
| Sep 30, 2022 | -220.90% |
| Jun 30, 2022 | -131.88% |
| Mar 31, 2022 | -83.50% |
| Dec 31, 2021 | -54.14% |
| Sep 30, 2021 | -104.54% |
API Access
Unicycive Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=UNCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "UNCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=UNCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();